Published in Biotechnol Bioeng on November 01, 1992
Comparison of x-ray crystal structures of an acyl-enzyme intermediate of subtilisin Carlsberg formed in anhydrous acetonitrile and in water. Proc Natl Acad Sci U S A (1998) 0.95
Theatre over-shoes do not reduce operating theatre floor bacterial counts. J Hosp Infect (1991) 1.92
Coherence between low-frequency activation of the motor cortex and tremor in patients with essential tremor. Lancet (2000) 1.72
Rational modification of enzyme catalysis by engineering surface charge. Nature (1987) 1.71
Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry (2008) 1.67
Effects of mechanical signaling on plant cell cytosolic calcium. Proc Natl Acad Sci U S A (1995) 1.63
Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene (1998) 1.56
Prediction of electrostatic effects of engineering of protein charges. Nature (1987) 1.44
A hysterographic study of the abdominal hysterotomy scar. J Obstet Gynaecol Br Commonw (1969) 1.26
Guidelines for dyspepsia management in general practice using focus groups. Br J Gen Pract (1997) 1.23
Electrostatic effects on modification of charged groups in the active site cleft of subtilisin by protein engineering. J Mol Biol (1987) 1.20
Nerve agents degraded by enzymatic foams. Nature (1998) 1.14
Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications. Br J Clin Pharmacol (1976) 1.07
Structure and mechanism of arylamine N-acetyltransferases. Curr Top Med Chem (2006) 1.03
The Scar-in-a-Jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. Br J Pharmacol (2009) 1.03
The effect of surgical theatre head-gear on air bacterial counts. J Hosp Infect (1991) 1.00
Light-induced tailoring of PEG-hydrogel properties. Biomaterials (1998) 0.98
Creating molecular barriers to acute platelet deposition on damaged arteries with reactive polyethylene glycol. J Biomed Mater Res (1998) 0.96
Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol. Biomaterials (1998) 0.92
Role of diffusion in nonaqueous enzymology. 1. Theory. Enzyme Microb Technol (1992) 0.91
The role of hydration in enzyme activity and stability: 2. Alcohol dehydrogenase activity and stability in a continuous gas phase reactor. Biotechnol Bioeng (1996) 0.90
Treatment of rat pancreatic islets with reactive PEG. Biomaterials (2000) 0.90
No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure. Fertil Steril (1998) 0.87
Efficient total gene synthesis of 1.35-kb hybrid alpha-lytic protease gene using the polymerase chain reaction. PCR Methods Appl (1993) 0.86
A novel missense mutation (S18N) in the 5' non-HMG box region of the SRY gene in a patient with partial gonadal dysgenesis and his normal male relatives. Hum Genet (1998) 0.85
IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up. Acta Psychiatr Scand (2002) 0.84
Peritoneal cystic mesothelioma: an electron microscopic and immunohistochemical study of two male patients. J Clin Pathol (1986) 0.83
Salmonella vascular graft infection. Lancet (1991) 0.82
Enzymatic catalysis of formation of Z-aspartame in ionic liquid - An alternative to enzymatic catalysis in organic solvents. Biotechnol Prog (2000) 0.82
Enzymatic dehalogenation of gas phase substrates with haloalkane dehalogenase. Biotechnol Bioeng (2000) 0.82
Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol. Biomaterials (1999) 0.81
Protein extraction and activity in reverse micelles of a nonionic detergent. Biotechnol Bioeng (1992) 0.80
An inpatient treatment model for adults with mild intellectual disability and challenging behaviour. J Intellect Disabil Res (1999) 0.79
Synthesis of protein-containing polymers in organic solvents. Biotechnol Bioeng (1995) 0.79
Differential expression of CD32 isoforms following alloactivation of human T cells. Immunology (1997) 0.79
Biocatalytic nerve agent detoxification in fire fighting foams. Biotechnol Bioeng (1999) 0.79
Are the Health of the Nation's targets attainable? Postal survey of general practitioner's views. BMJ (1997) 0.79
Biocatalytic synthesis of fluorinated polyesters. Biotechnol Prog (2000) 0.79
Biocatalytic synthesis of acrylates in organic solvents and supercritical fluids: III. Does carbon dioxide covalently modify enzymes? Biotechnol Bioeng (1995) 0.78
Transmission electron microscopy of percutaneous fine needle aspirates from lung: a study of 70 cases. Thorax (1987) 0.78
Photoimmobilization of organophosphorus hydrolase within a PEG-based hydrogel. Biotechnol Bioeng (1999) 0.78
Thermoinactivation of diisopropylfluorophosphatase-containing polyurethane polymers. Biomacromolecules (2001) 0.78
Sausage: protein threading with flexible force fields. Bioinformatics (1999) 0.78
Covalent binding of a nerve agent hydrolyzing enzyme within polyurethane foams. Biotechnol Bioeng (1996) 0.78
Psychological treatment for obsessive-compulsive disorder in people with autism spectrum disorders--a pilot study. Psychother Psychosom (2008) 0.78
Degradation of pesticides in a continuous-flow two-phase microemulsion reactor. Biotechnol Prog (1994) 0.77
Gender differences in psychogenic non-epileptic seizures. Seizure (2005) 0.77
Solubilization of subtilisin in CO2 using fluoroether-functional amphiphiles. Biotechnol Bioeng (1998) 0.77
Dramatically stabilized phosphotriesterase-polymers for nerve agent degradation. Biotechnol Bioeng (1997) 0.77
New members of the 3 beta-hydroxysteroid dehydrogenase gene family. Mol Cell Probes (1995) 0.77
Phenotypic variability and origins of mutations in the gene encoding 3beta-hydroxysteroid dehydrogenase type II. J Mol Endocrinol (2000) 0.77
Enzymatic synthesis of carbonate monomers and polycarbonates. Biotechnol Bioeng (1999) 0.77
Organophosphate skin decontamination using immobilized enzymes. Chem Biol Interact (1999) 0.76
Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. J Mol Endocrinol (1994) 0.76
A comparison of lipase-catalyzed ester hydrolysis in reverse micelles, organic solvents, and biphasic systems. Biotechnol Bioeng (1995) 0.76
Biocatalytic synthesis of acrylates in supercritical fluids: tuning enzyme activity by changing pressure. Proc Natl Acad Sci U S A (1993) 0.75
Chronic vitamin E deficiency causing spinocerebellar degeneration, peripheral neuropathy, and centro-cecal scotomata. Nutrition (1999) 0.75
Prognosis of abdominal aortic aneurysm. BMJ (1990) 0.75
Letters to the editor. Gut (1991) 0.75
Genotyping of the type II 3beta-hydroxysteroid dehydrogenase gene (HSD3B2) in women with hirsutism and elevated ACTH-stimulated delta(5)-steroids. Fertil Steril (2000) 0.75
Human 3 beta-hydroxysteroid dehydrogenase: genes and phenotypes. J Mol Endocrinol (1996) 0.75
Modification of enzyme catalysis by engineering surface charge. Methods Enzymol (1991) 0.75
Modern forceps delivery. Midwife Health Visit (1969) 0.75
Two-Step biocatalytic conversion of an ester to an aldehyde in reverse micelles. Biotechnol Bioeng (1994) 0.75
High pressure EPR studies of protein mobility in reversed micelles. Biotechnol Bioeng (1994) 0.75
Enzyme-catalyzed polycondensation reactions for the synthesis of aromatic polycarbonates and polyesters. Biotechnol Bioeng (1999) 0.75
Ureteral obstruction following aortobifemoral bypass: management by endoscopic balloon dilation. J Urol (1992) 0.75
Fighting nerve agent chemical weapons with enzyme technology. Ann N Y Acad Sci (1998) 0.75
Haloalkane hydrolysis with an immobilized haloalkane dehalogenase. Biotechnol Bioeng (2001) 0.75
Unilateral arm tremor as the sole feature of ischemic stroke: a 5-year follow up. Mov Disord (2000) 0.75
Solubilization and activity of proteins in compressible-fluid based microemulsions. Biotechnology (N Y) (1992) 0.75
A novel homozygous nonsense mutations E135* in the type II 3beta-hydroxysteroid dehydrogenase gene in a girl with salt-losing congenital adrenal hyperplasia. Mutations in brief no. 168. Online. Hum Mutat (1998) 0.75
Nonaqueous biocatalytic degradation of a nerve gas mimic. Biotechnol Prog (1995) 0.75
Endoscopic balloon tamponade of iatrogenic bleeding from oesophageal varices. Br J Surg (1991) 0.75
Biocatalytic polyester synthesis: analysis of the evolution of molecular weight and end group functionality. Biotechnol Bioeng (1997) 0.75
The effect of socioeconomic status on treatment and pregnancy outcomes in women with epilepsy in Scotland. Epilepsy Behav (2013) 0.75
Effect of hydration on the morphology of enzyme powder. Biotechnol Bioeng (1992) 0.75
Irreversible immobilization of diisopropylfluorophosphatase in polyurethane polymers. Biomacromolecules (2000) 0.75
The human 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene cluster on chromosome 1p13 contains a presumptive pseudogene; 3 beta-HSD and CYP17 do not segregate with dominantly inherited hirsutism. J Mol Endocrinol (1995) 0.75
Biodegradation of pesticides in nonionic water-in-oil microemulsions of tween 85: Relationship between micelle structure and activity. Biotechnol Bioeng (1994) 0.75
Biocatalytic synthesis of acrylates in organic solvents and supercritical fluids: I. optimization of enzyme environment. Biotechnol Bioeng (1992) 0.75
The role of hydration in enzyme activity and stability: 1. Water adsorption by alcohol dehydrogenase in a continuous gas phase reactor. Biotechnol Bioeng (1996) 0.75
A diabetic survey in a Suffolk rural practice. J Coll Gen Pract (1967) 0.75
Use of a batch-stirred reactor to rationally tailor biocatalytic polytransesterification. Biotechnol Bioeng (2000) 0.75